Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 11/18/15  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Lloyd H. Kasper MD

Wrong Dr. Lloyd H. Kasper MD?

Professor of Immunology and Micro...

Phone: (603) ***-****  HQ Phone
Geisel School of Medicine at Dartmouth
One Medical Center Dr (HB 7070)
Lebanon , New Hampshire 03756
United States

 
Background

Employment History

Board Memberships and Affiliations

Education

  • M.D.
47 Total References
Web References
Dr. Lloyd ...
www.psychosomatic.org [cached]
Dr. Lloyd Kasper
...
Lloyd H Kasper, MD
Dr. Lloyd Kasper is a Professor of Immunology/Microbiology and Medicine at Geisel School of Medicine where he has been actively involved in basic and applied immunology supported by research grants from the National Institutes of Health, March of Dimes, National Multiple Sclerosis Society and industry. He established and directed the Dartmouth MS Center for over 20 years. His basic research interests are related to understanding immunopathogenesis of CNS demyelinating disease, the role of specific immune regulatory populations in disease control and the role of the gut microbiome in CNS demyelination. Dr. Kasper has authored over 175 research and clinical articles related to these interests. He has been the primary organizer for several Keystone Symposia most recently the Microbiome: Effector/Regulatory Networks. When not doing science at Dartmouth, Kasper can be found painting in his studio in Taos, New Mexico.
Biosciences « B2B News
www.tizinc.com [cached]
Symbiotix' lead clinical candidate, Polysaccharide A (PSA), is the first molecule to emerge from the microbiome and the $2.3 million NIH award enables the completion of key translational studies and production of material needed to take into human clinical trials as a novel treatment for multiple sclerosis (MS), said Prof. Lloyd Kasper, Professor of Medicine, Microbiology and Immunology at Geisel School of Medicine at Dartmouth College, and Co-Founder of Symbiotix.
PSA is a first-in-class oral therapy that works through a novel mechanism of action related to activation of regulatory T cells, which exert an anti-inflammatory effect through the production of IL-10.
"Current FDA-approved therapies for multiple sclerosis offer only partial benefit for reduction of relapses and time to disability. However, all of these FDA-approved treatments have side effects some of which can be rather profound," said Prof. Kasper. "We are developing PSA as a safe and effective new oral therapy for the over 500,000 US patients with multiple sclerosis.
Biosciences « B2B News
pr.tizinc.com [cached]
Symbiotix' lead clinical candidate, Polysaccharide A (PSA), is the first molecule to emerge from the microbiome and the $2.3 million NIH award enables the completion of key translational studies and production of material needed to take into human clinical trials as a novel treatment for multiple sclerosis (MS), said Prof. Lloyd Kasper, Professor of Medicine, Microbiology and Immunology at Geisel School of Medicine at Dartmouth College, and Co-Founder of Symbiotix.
PSA is a first-in-class oral therapy that works through a novel mechanism of action related to activation of regulatory T cells, which exert an anti-inflammatory effect through the production of IL-10.
"Current FDA-approved therapies for multiple sclerosis offer only partial benefit for reduction of relapses and time to disability. However, all of these FDA-approved treatments have side effects some of which can be rather profound," said Prof. Kasper. "We are developing PSA as a safe and effective new oral therapy for the over 500,000 US patients with multiple sclerosis.
Understanding the microbiota in ...
www.psychosomatic.org [cached]
Understanding the microbiota in neurological diseases - Lloyd H Kasper, MD
W. A. Smith, Inc. New England Finest Auctions
www.wsmithauction.com [cached]
Lot 99: Painted by Dr. Lloyd Kasper, Neurologist and Director of the Multiple Sclerosis Center at DHMC. Dr. Kasper has been painting long before he arrived at Dartmouth Medical School back in 1983. His paintings adorn the walls of his office and the corridors on the 7th floor of the Rubin Building at DHMC. -- Sold for $200
Other People with the name "Kasper":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304